BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19775667)

  • 1. Portrait of invasive lobular carcinoma of the breast.
    Pestalozzi BC
    Eur J Cancer; 2009 Sep; 45 Suppl 1():450-1. PubMed ID: 19775667
    [No Abstract]   [Full Text] [Related]  

  • 2. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of recurrent invasive lobular carcinoma of the breast found as metastasis to the duodenum.
    Nihon-Yanagi Y; Park Y; Ooshiro M; Aoki H; Suzuki Y; Hiruta N; Kameda N; Katoh R
    Breast Cancer; 2009; 16(1):83-7. PubMed ID: 18386118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading of infiltrating lobular carcinoma.
    Mokbel K
    Eur J Surg Oncol; 2001 Sep; 27(6):609-10. PubMed ID: 11520101
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of lobular carcinoma in situ of the breast.
    Osborne MP; Hoda SA
    Oncology (Williston Park); 1994 Feb; 8(2):45-9; discussion 49, 53-4. PubMed ID: 8167087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy.
    Hwang N; Schiller DE; Crystal P; Maki E; McCready DR
    Ann Surg Oncol; 2009 Nov; 16(11):3000-9. PubMed ID: 19603233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A confusing cancer.
    Health News; 1998 Aug; 4(10):1-2. PubMed ID: 9708039
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
    Stolier AJ; Barre G; Bolton JS; Fuhrman GM; Looney S
    Am Surg; 2004 Sep; 70(9):818-21. PubMed ID: 15481302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast.
    Warneke J; Berger R; Johnson C; Stea D; Villar H
    Am J Surg; 1996 Nov; 172(5):496-500. PubMed ID: 8942552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma.
    Dillon MF; Hill AD; Fleming FJ; O'Doherty A; Quinn CM; McDermott EW; O'Higgins N
    Am J Surg; 2006 Feb; 191(2):201-5. PubMed ID: 16442946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8. The dilemma of in situ carcinoma of the breast.
    Fentiman IS
    Int J Clin Pract; 2001 Dec; 55(10):680-3. PubMed ID: 11777293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic lobulitis and carcinoma of the breast.
    Lee AH; Millis RR; Bobrow LG
    Histopathology; 1996 Jan; 28(1):94-5. PubMed ID: 8838131
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infiltrating lobular breast cancer: histological and immunohistochemical characteristics].
    Vishnevskaia IaV; Ermilova VD; Savelov NA; Nechushkin MI; Trigolosov AV; Petrovskiĭ AV; Chemeris GIu; Zakharova TI
    Arkh Patol; 2005; 67(4):17-21. PubMed ID: 16209292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS; Bendall S; Bates T
    Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive lobular breast carcinoma mimicking medullary carcinoma.
    Terasaki Y; Sato S; Yoshida H; Iezumi K; Suto A; Takeshita T; Omiya H; Kijima H
    Acta Cytol; 1998; 42(3):812-5. PubMed ID: 9622715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.